Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1997 Sep;105(9):928–939. doi: 10.1289/ehp.97105928

Renal effects of environmental and occupational lead exposure.

M Loghman-Adham 1
PMCID: PMC1470371  PMID: 9300927

Abstract

Environmental and industrial lead exposures continue to pose major public health problems in children and in adults. Acute exposure to high concentrations of lead can result in proximal tubular damage with characteristic histologic features and manifested by glycosuria and aminoaciduria. Chronic occupational exposure to lead, or consumption of illicit alcohol adulterated with lead, has also been linked to a high incidence of renal dysfunction, which is characterized by glomerular and tubulointerstitial changes resulting in chronic renal failure, hypertension, hyperuricemia, and gout. A high incidence of nephropathy was reported during the early part of this century from Queensland, Australia, in persons with a history of childhood lead poisoning. No such sequela has been found in studies of three cohorts of lead-poisoned children from the United States. Studies in individuals with low-level lead exposure have shown a correlation between blood lead levels and serum creatinine or creatinine clearance. Chronic low-level exposure to lead is also associated with increased urinary excretion of low molecular weight proteins and lysosomal enzymes. The relationship between renal dysfunction detected by these sensitive tests and the future development of chronic renal disease remains uncertain. Epidemiologic studies have shown an association between blood lead levels and blood pressure, and hypertension is a cardinal feature of lead nephropathy. Evidence for increased body lead burden is a prerequisite for the diagnosis of lead nephropathy. Blood lead levels are a poor indicator of body lead burden and reflect recent exposure. The EDTA lead mobilization test has been used extensively in the past to assess body lead burden. It is now replaced by the less invasive in vivo X-ray fluorescence for determination of bone lead content.

Full text

PDF
928

Images in this article

928p928-a
on p.928
929Figure 1.
on p.929
930Figure 2.
on p.930
930Figure 2.
on p.930
934Figure 3.
on p.934

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahlgren L., Mattsson S. An X-ray fluorescence technique for in vivo determination of lead concentration in a bone matrix. Phys Med Biol. 1979 Jan;24(1):136–145. doi: 10.1088/0031-9155/24/1/011. [DOI] [PubMed] [Google Scholar]
  2. Aviv A., John E., Bernstein J., Goldsmith D. I., Spitzer A. Lead intoxication during development: its late effects on kidney function and blood pressure. Kidney Int. 1980 Apr;17(4):430–437. doi: 10.1038/ki.1980.51. [DOI] [PubMed] [Google Scholar]
  3. Baker E. L., Jr, Landrigan P. J., Barbour A. G., Cox D. H., Folland D. S., Ligo R. N., Throckmorton J. Occupational lead poisoning in the United States: clinical and biochemical findings related to blood lead levels. Br J Ind Med. 1979 Nov;36(4):314–322. doi: 10.1136/oem.36.4.314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ball G. V., Sorensen L. B. Pathogenesis of hyperuricemia in saturinine gout. N Engl J Med. 1969 May 29;280(22):1199–1202. doi: 10.1056/NEJM196905292802203. [DOI] [PubMed] [Google Scholar]
  5. Barry P. S., Mossman D. B. Lead concentrations in human tissues. Br J Ind Med. 1970 Oct;27(4):339–351. doi: 10.1136/oem.27.4.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Batuman V., Dreisbach A., Chun E., Naumoff M. Lead increases red cell sodium-lithium countertransport. Am J Kidney Dis. 1989 Sep;14(3):200–203. doi: 10.1016/s0272-6386(89)80071-x. [DOI] [PubMed] [Google Scholar]
  7. Batuman V., Landy E., Maesaka J. K., Wedeen R. P. Contribution of lead to hypertension with renal impairment. N Engl J Med. 1983 Jul 7;309(1):17–21. doi: 10.1056/NEJM198307073090104. [DOI] [PubMed] [Google Scholar]
  8. Batuman V. Lead nephropathy, gout, and hypertension. Am J Med Sci. 1993 Apr;305(4):241–247. doi: 10.1097/00000441-199304000-00008. [DOI] [PubMed] [Google Scholar]
  9. Batuman V., Maesaka J. K., Haddad B., Tepper E., Landy E., Wedeen R. P. The role of lead in gout nephropathy. N Engl J Med. 1981 Feb 26;304(9):520–523. doi: 10.1056/NEJM198102263040905. [DOI] [PubMed] [Google Scholar]
  10. Bennett W. M. Lead nephropathy. Kidney Int. 1985 Aug;28(2):212–220. doi: 10.1038/ki.1985.143. [DOI] [PubMed] [Google Scholar]
  11. Bernard A. M., Vyskocil A., Roels H., Kriz J., Kodl M., Lauwerys R. Renal effects in children living in the vicinity of a lead smelter. Environ Res. 1995 Feb;68(2):91–95. doi: 10.1006/enrs.1995.1012. [DOI] [PubMed] [Google Scholar]
  12. Bernard A., Lauwerys R. Epidemiological application of early markers of nephrotoxicity. Toxicol Lett. 1989 Mar;46(1-3):293–306. doi: 10.1016/0378-4274(89)90137-9. [DOI] [PubMed] [Google Scholar]
  13. Bernard B. P., Becker C. E. Environmental lead exposure and the kidney. J Toxicol Clin Toxicol. 1988;26(1-2):1–34. doi: 10.3109/15563658808995395. [DOI] [PubMed] [Google Scholar]
  14. Boscolo P., Carmignani M. Neurohumoral blood pressure regulation in lead exposure. Environ Health Perspect. 1988 Jun;78:101–106. doi: 10.1289/ehp.8878101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Buchet J. P., Roels H., Bernard A., Lauwerys R. Assessment of renal function of workers exposed to inorganic lead, calcium or mercury vapor. J Occup Med. 1980 Nov;22(11):741–750. [PubMed] [Google Scholar]
  16. CHISOLM J. J., Jr Aminoaciduria as a manifestation of renal tubular injury in lead intoxication and a comparison with patterns of aminoaciduria seen in other diseases. J Pediatr. 1962 Jan;60:1–17. doi: 10.1016/s0022-3476(62)80002-x. [DOI] [PubMed] [Google Scholar]
  17. CHISOLM J. J., Jr, HARRISON H. C., EBERLEIN W. R., HARRISON H. E. Amino-aciduria, hypophosphatemia, and rickets in lead poisoning; study of a case. AMA Am J Dis Child. 1955 Feb;89(2):159–168. [PubMed] [Google Scholar]
  18. CRUTCHER J. C. CLINICAL MANIFESTATIONS AND THERAPY OF ACUTE LEAD INTOXICATION DUE TO THE INGESTION OF ILLICITLY DISTILLED ALCOHOL. Ann Intern Med. 1963 Nov;59:707–715. doi: 10.7326/0003-4819-59-5-707. [DOI] [PubMed] [Google Scholar]
  19. Campbell B. C., Beattie A. D., Moore M. R., Goldberg A., Reid A. G. Renal insufficiency associated with excessive lead exposure. Br Med J. 1977 Feb 19;1(6059):482–485. doi: 10.1136/bmj.1.6059.482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Campbell B. C., Meredith P. A., Scott J. J. Lead exposure and changes in the renin-angiotensin-aldosterone system in man. Toxicol Lett. 1985 Apr;25(1):25–32. doi: 10.1016/0378-4274(85)90096-7. [DOI] [PubMed] [Google Scholar]
  21. Chai S. S., Webb R. C. Effects of lead on vascular reactivity. Environ Health Perspect. 1988 Jun;78:85–89. doi: 10.1289/ehp.887885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Chia K. S., Jeyaratnam J., Lee J., Tan C., Ong H. Y., Ong C. N., Lee E. Lead-induced nephropathy: relationship between various biological exposure indices and early markers of nephrotoxicity. Am J Ind Med. 1995 Jun;27(6):883–895. doi: 10.1002/ajim.4700270612. [DOI] [PubMed] [Google Scholar]
  23. Chia K. S., Jeyaratnam J., Tan C., Ong H. Y., Ong C. N., Lee E. Glomerular function of lead-exposed workers. Toxicol Lett. 1995 May;77(1-3):319–328. doi: 10.1016/0378-4274(95)03313-0. [DOI] [PubMed] [Google Scholar]
  24. Chia K. S., Mutti A., Alinovi R., Jeyaratnam J., Tan C., Ong C. N., Lee E. Urinary excretion of tubular brush-border antigens among lead exposed workers. Ann Acad Med Singapore. 1994 Sep;23(5):655–659. [PubMed] [Google Scholar]
  25. Chia K. S., Mutti A., Tan C., Ong H. Y., Jeyaratnam J., Ong C. N., Lee E. Urinary N-acetyl-beta-D-glucosaminidase activity in workers exposed to inorganic lead. Occup Environ Med. 1994 Feb;51(2):125–129. doi: 10.1136/oem.51.2.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Cooper W. C., Gaffey W. R. Mortality of lead workers. J Occup Med. 1975 Feb;17(2):100–107. doi: 10.1097/00043764-197502000-00012. [DOI] [PubMed] [Google Scholar]
  27. Craswell P. W. Chronic lead nephropathy. Annu Rev Med. 1987;38:169–173. doi: 10.1146/annurev.me.38.020187.001125. [DOI] [PubMed] [Google Scholar]
  28. Craswell P. W., Price J., Boyle P. D., Heazlewood V. J., Baddeley H., Lloyd H. M., Thomas B. J., Thomas B. W. Chronic renal failure with gout: a marker of chronic lead poisoning. Kidney Int. 1984 Sep;26(3):319–323. doi: 10.1038/ki.1984.175. [DOI] [PubMed] [Google Scholar]
  29. Craswell P. W., Price J., Boyle P. D., Heazlewood V. J., Baddeley H., Lloyd H. M., Thomas B. J., Thomas B. W., Williams G. M. Chronic lead nephropathy in Queensland: alternative methods of diagnosis. Aust N Z J Med. 1986 Feb;16(1):11–19. doi: 10.1111/j.1445-5994.1986.tb01107.x. [DOI] [PubMed] [Google Scholar]
  30. Cárdenas A., Roels H., Bernard A. M., Barbon R., Buchet J. P., Lauwerys R. R., Roselló J., Ramis I., Mutti A., Franchini I. Markers of early renal changes induced by industrial pollutants. II. Application to workers exposed to lead. Br J Ind Med. 1993 Jan;50(1):28–36. doi: 10.1136/oem.50.1.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. DANILOVIC V. Chronic nephritis due to ingestion of lead-contaminated flour. Br Med J. 1958 Jan 4;1(5061):27–28. doi: 10.1136/bmj.1.5061.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Davies J. M. Long term mortality study of chromate pigment workers who suffered lead poisoning. Br J Ind Med. 1984 May;41(2):170–178. doi: 10.1136/oem.41.2.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. EMMERSON B. T. CHRONIC LEAD NEPHROPATHY: THE DIAGNOSTIC USE OF CALCIUM EDTA AND THE ASSOCIATION WITH GOUT. Australas Ann Med. 1963 Nov;12:310–324. doi: 10.1111/imj.1963.12.4.310. [DOI] [PubMed] [Google Scholar]
  34. Elhelu M. A., Caldwell D. T., Hirpassa W. D. Lead in inner-city soil and its possible contribution to children's blood lead. Arch Environ Health. 1995 Mar-Apr;50(2):165–169. doi: 10.1080/00039896.1995.9940894. [DOI] [PubMed] [Google Scholar]
  35. Emmerson B. T. Chronic lead nephropathy. Kidney Int. 1973 Jul;4(1):1–5. doi: 10.1038/ki.1973.73. [DOI] [PubMed] [Google Scholar]
  36. Emmerson B. T. Lead stores in patients with renal insufficiency. Nephron. 1991;58(2):233–234. doi: 10.1159/000186421. [DOI] [PubMed] [Google Scholar]
  37. Emmerson B. T. The renal excretion of urate in chronic lead nephropathy. Australas Ann Med. 1965 Nov;14(4):295–303. doi: 10.1111/imj.1965.14.4.295. [DOI] [PubMed] [Google Scholar]
  38. Fels L. M., Herbort C., Pergande M., Jung K., Hotter G., Roselló J., Gelpi E., Mutti A., De Broe M., Stolte H. Nephron target sites in chronic exposure to lead. Nephrol Dial Transplant. 1994;9(12):1740–1746. [PubMed] [Google Scholar]
  39. Fleischer N., Mouw R., Vander A. J. Chronic effects of lead on renin and renal sodium excretion. J Lab Clin Med. 1980 May;95(5):759–770. [PubMed] [Google Scholar]
  40. Fournier L., Thomas G., Garnier R., Buisine A., Houze P., Pradier F., Dally S. 2,3-Dimercaptosuccinic acid treatment of heavy metal poisoning in humans. Med Toxicol Adverse Drug Exp. 1988 Nov-Dec;3(6):499–504. doi: 10.1007/BF03259898. [DOI] [PubMed] [Google Scholar]
  41. Gerhardsson L., Chettle D. R., Englyst V., Nordberg G. F., Nyhlin H., Scott M. C., Todd A. C., Vesterberg O. Kidney effects in long term exposed lead smelter workers. Br J Ind Med. 1992 Mar;49(3):186–192. doi: 10.1136/oem.49.3.186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Goyer R. A. Lead and the kidney. Curr Top Pathol. 1971;55:147–176. doi: 10.1007/978-3-642-65208-0_5. [DOI] [PubMed] [Google Scholar]
  43. Goyer R. A. Lead and the kidney. Curr Top Pathol. 1971;55:147–176. doi: 10.1007/978-3-642-65208-0_5. [DOI] [PubMed] [Google Scholar]
  44. Goyer R. A. Lead toxicity: current concerns. Environ Health Perspect. 1993 Apr;100:177–187. doi: 10.1289/ehp.93100177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Goyer R. A., Leonard D. L., Bream P. R., Irons T. G. Aminoaciduria in experimental lead poisoning. Proc Soc Exp Biol Med. 1970 Dec;135(3):767–771. doi: 10.3181/00379727-135-35140. [DOI] [PubMed] [Google Scholar]
  46. Goyer R. A., Mahaffey K. R. Susceptibility to lead toxicity. Environ Health Perspect. 1972 Oct;2:73–80. doi: 10.1289/ehp.720273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Goyer R. A., May P., Cates M. M., Krigman M. R. Lead and protein content of isolated intranuclear inclusion bodies from kidneys of lead-poisoned rats. Lab Invest. 1970 Mar;22(3):245–251. [PubMed] [Google Scholar]
  48. Goyer R. A. Mechanisms of lead and cadmium nephrotoxicity. Toxicol Lett. 1989 Mar;46(1-3):153–162. doi: 10.1016/0378-4274(89)90124-0. [DOI] [PubMed] [Google Scholar]
  49. Goyer R. A. The renal tubule in lead poisoning. I. mMitochondrial swelling and aminoacidura. Lab Invest. 1968 Jul;19(1):71–77. [PubMed] [Google Scholar]
  50. Greenberg A., Parkinson D. K., Fetterolf D. E., Puschett J. B., Ellis K. J., Wielopolski L., Vaswani A. N., Cohn S. H., Landrigan P. J. Effects of elevated lead and cadmium burdens on renal function and calcium metabolism. Arch Environ Health. 1986 Mar-Apr;41(2):69–76. doi: 10.1080/00039896.1986.9937412. [DOI] [PubMed] [Google Scholar]
  51. HENDERSON D. A. A follow-up of cases of plumbism in children. Australas Ann Med. 1954 Aug;3(3):219–224. doi: 10.1111/imj.1954.3.3.219. [DOI] [PubMed] [Google Scholar]
  52. HENDERSON D. A., INGLIS J. A. The lead content of bone in chronic Bright's disease. Australas Ann Med. 1957 May;6(2):145–154. doi: 10.1111/imj.1957.6.2.145. [DOI] [PubMed] [Google Scholar]
  53. Hammond P. B. Exposure of humans to lead. Annu Rev Pharmacol Toxicol. 1977;17:197–214. doi: 10.1146/annurev.pa.17.040177.001213. [DOI] [PubMed] [Google Scholar]
  54. Harlan W. R., Landis J. R., Schmouder R. L., Goldstein N. G., Harlan L. C. Blood lead and blood pressure. Relationship in the adolescent and adult US population. JAMA. 1985 Jan 25;253(4):530–534. doi: 10.1001/jama.253.4.530. [DOI] [PubMed] [Google Scholar]
  55. Hense H. W., Filipiak B., Keil U. The association of blood lead and blood pressure in population surveys. Epidemiology. 1993 Mar;4(2):173–179. doi: 10.1097/00001648-199303000-00014. [DOI] [PubMed] [Google Scholar]
  56. Hertz-Picciotto I., Croft J. Review of the relation between blood lead and blood pressure. Epidemiol Rev. 1993;15(2):352–373. doi: 10.1093/oxfordjournals.epirev.a036125. [DOI] [PubMed] [Google Scholar]
  57. Hong C. D., Hanenson I. B., Lerner S., Hammond P. B., Pesce A. J., Pollak V. E. Occupational exposure to lead: effects on renal function. Kidney Int. 1980 Oct;18(4):489–494. doi: 10.1038/ki.1980.162. [DOI] [PubMed] [Google Scholar]
  58. Hu H. A 50-year follow-up of childhood plumbism. Hypertension, renal function, and hemoglobin levels among survivors. Am J Dis Child. 1991 Jun;145(6):681–687. doi: 10.1001/archpedi.1991.02160060099029. [DOI] [PubMed] [Google Scholar]
  59. Hu H., Aro A., Payton M., Korrick S., Sparrow D., Weiss S. T., Rotnitzky A. The relationship of bone and blood lead to hypertension. The Normative Aging Study. JAMA. 1996 Apr 17;275(15):1171–1176. [PubMed] [Google Scholar]
  60. Hu H., Milder F. L., Burger D. E. X-ray fluorescence measurements of lead burden in subjects with low-level community lead exposure. Arch Environ Health. 1990 Nov-Dec;45(6):335–341. doi: 10.1080/00039896.1990.10118752. [DOI] [PubMed] [Google Scholar]
  61. Inglis J. A., Henderson D. A., Emmerson B. T. The pathology and pathogenesis of chronic lead nephropathy occurring in Queensland. J Pathol. 1978 Feb;124(2):65–76. doi: 10.1002/path.1711240202. [DOI] [PubMed] [Google Scholar]
  62. Kaliuzhnyi L. V., Litvinova S. V., Kaliuzhnyi A. L., Aristova V. V., Gruden' M. A., Kozlov A. Iu, Torgovanova G. V., Fedoseeva O. V. Antitela k morfinu v mekhanizmakh morfinnoi rezistentnosti, morfinnoi tolerantnosti i deistviia antagonista. Eksp Klin Farmakol. 1998 Jan-Feb;61(1):21–24. [PubMed] [Google Scholar]
  63. Khalil-Manesh F., Gonick H. C., Cohen A. H., Alinovi R., Bergamaschi E., Mutti A., Rosen V. J. Experimental model of lead nephropathy. I. Continuous high-dose lead administration. Kidney Int. 1992 May;41(5):1192–1203. doi: 10.1038/ki.1992.181. [DOI] [PubMed] [Google Scholar]
  64. Khalil-Manesh F., Gonick H. C., Cohen A. H. Experimental model of lead nephropathy. III. Continuous low-level lead administration. Arch Environ Health. 1993 Jul-Aug;48(4):271–278. doi: 10.1080/00039896.1993.9940372. [DOI] [PubMed] [Google Scholar]
  65. Khalil-Manesh F., Gonick H. C., Cohen A., Bergamaschi E., Mutti A. Experimental model of lead nephropathy. II. Effect of removal from lead exposure and chelation treatment with dimercaptosuccinic acid (DMSA). Environ Res. 1992 Jun;58(1):35–54. doi: 10.1016/s0013-9351(05)80203-8. [DOI] [PubMed] [Google Scholar]
  66. Kim R., Rotnitsky A., Sparrow D., Weiss S., Wager C., Hu H. A longitudinal study of low-level lead exposure and impairment of renal function. The Normative Aging Study. JAMA. 1996 Apr 17;275(15):1177–1181. [PubMed] [Google Scholar]
  67. Konishi Y., Endo G., Kiyota A., Horiguchi S. Fractional clearances of low molecular weight proteins in lead workers. Ind Health. 1994;32(3):119–127. doi: 10.2486/indhealth.32.119. [DOI] [PubMed] [Google Scholar]
  68. Kopp S. J., Barron J. T., Tow J. P. Cardiovascular actions of lead and relationship to hypertension: a review. Environ Health Perspect. 1988 Jun;78:91–99. doi: 10.1289/ehp.887891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Kumar B. D., Krishnaswamy K. Detection of occupational lead nephropathy using early renal markers. J Toxicol Clin Toxicol. 1995;33(4):331–335. doi: 10.3109/15563659509028918. [DOI] [PubMed] [Google Scholar]
  70. LUDWIG G. D. Saturnine gout; a secondary type of gout. AMA Arch Intern Med. 1957 Nov;100(5):802–812. doi: 10.1001/archinte.1957.00260110118017. [DOI] [PubMed] [Google Scholar]
  71. Landrigan P. J., Todd A. C. Direct measurement of lead in bone. A promising biomarker. JAMA. 1994 Jan 19;271(3):239–240. [PubMed] [Google Scholar]
  72. Landrigan P. J. Toxicity of lead at low dose. Br J Ind Med. 1989 Sep;46(9):593–596. doi: 10.1136/oem.46.9.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Lilis R., Fischbein A., Valciukas J. A., Blumberg W., Selikoff I. J. Kidney function and lead: relationships in several occupational groups with different levels of exposure. Am J Ind Med. 1980;1(3-4):405–412. doi: 10.1002/ajim.4700010318. [DOI] [PubMed] [Google Scholar]
  74. Lilis R., Gavrilescu N., Nestorescu B., Dumitriu C., Roventa A. Nephropathy in chronic lead poisoning. Br J Ind Med. 1968 Jul;25(3):196–202. doi: 10.1136/oem.25.3.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Lin J. L., Yeh K. H., Tseng H. C., Chen W. Y., Lai H. H., Lin Y. C. Urinary N-acetyl-glucosaminidase excretion and environmental lead exposure. Green Cross Health Service Association Study Group. Am J Nephrol. 1993;13(6):442–447. doi: 10.1159/000168661. [DOI] [PubMed] [Google Scholar]
  76. Malcolm D., Barnett H. A. A mortality study of lead workers 1925-76. Br J Ind Med. 1982 Nov;39(4):404–410. doi: 10.1136/oem.39.4.404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Mann K. V., Travers J. D. Succimer, an oral lead chelator. Clin Pharm. 1991 Dec;10(12):914–922. [PubMed] [Google Scholar]
  78. Markowitz M. E., Rosen J. F. Assessment of lead stores in children: validation of an 8-hour CaNa2EDTA provocative test. J Pediatr. 1984 Mar;104(3):337–341. doi: 10.1016/s0022-3476(84)81091-4. [DOI] [PubMed] [Google Scholar]
  79. McDonald J. A., Potter N. U. Lead's legacy? Early and late mortality of 454 lead-poisoned children. Arch Environ Health. 1996 Mar-Apr;51(2):116–121. doi: 10.1080/00039896.1996.9936003. [DOI] [PubMed] [Google Scholar]
  80. Meyer B. R., Fischbein A., Rosenman K., Lerman Y., Drayer D. E., Reidenberg M. M. Increased urinary enzyme excretion in workers exposed to nephrotoxic chemicals. Am J Med. 1984 Jun;76(6):989–998. doi: 10.1016/0002-9343(84)90847-7. [DOI] [PubMed] [Google Scholar]
  81. Moel D. I., Sachs H. K. Renal function 17 to 23 years after chelation therapy for childhood plumbism. Kidney Int. 1992 Nov;42(5):1226–1231. doi: 10.1038/ki.1992.408. [DOI] [PubMed] [Google Scholar]
  82. Moore J. F., Goyer R. A., Wilson M. Lead-induced inclusion bodies. Solubility, amino acid content, and relationship to residual acidic nuclear proteins. Lab Invest. 1973 Nov;29(5):488–494. [PubMed] [Google Scholar]
  83. Morgan J. M., Hartley M. W., Miller R. E. Nephropathy in chronic lead poisoning. Arch Intern Med. 1966 Jul;118(1):17–29. [PubMed] [Google Scholar]
  84. Morris C., McCarron D. A., Bennett W. M. Low-level lead exposure, blood pressure, and calcium metabolism. Am J Kidney Dis. 1990 Jun;15(6):568–574. doi: 10.1016/s0272-6386(12)80528-2. [DOI] [PubMed] [Google Scholar]
  85. Murdiati T. B., McSweeney C. S., Campbell R. S., Stoltz D. S. Prevention of hydrolysable tannin toxicity in goats fed Clidemia hirta by calcium hydroxide supplementation. J Appl Toxicol. 1990 Oct;10(5):325–331. doi: 10.1002/jat.2550100504. [DOI] [PubMed] [Google Scholar]
  86. Mushak P. Defining lead as the premiere environmental health issue for children in America: criteria and their quantitative application. Environ Res. 1992 Dec;59(2):281–309. doi: 10.1016/s0013-9351(05)80036-2. [DOI] [PubMed] [Google Scholar]
  87. Needleman H. L., Gatsonis C. A. Low-level lead exposure and the IQ of children. A meta-analysis of modern studies. JAMA. 1990 Feb 2;263(5):673–678. [PubMed] [Google Scholar]
  88. Nolan C. V., Shaikh Z. A. Lead nephrotoxicity and associated disorders: biochemical mechanisms. Toxicology. 1992;73(2):127–146. doi: 10.1016/0300-483x(92)90097-x. [DOI] [PubMed] [Google Scholar]
  89. Nuyts G. D., Daelemans R. A., Jorens P. G., Elseviers M. M., Van de Vyver F. L., De Broe M. E. Does lead play a role in the development of chronic renal disease? Nephrol Dial Transplant. 1991;6(5):307–315. doi: 10.1093/ndt/6.5.307. [DOI] [PubMed] [Google Scholar]
  90. Omae K., Sakurai H., Higashi T., Muto T., Ichikawa M., Sasaki N. No adverse effects of lead on renal function in lead-exposed workers. Ind Health. 1990;28(2):77–83. doi: 10.2486/indhealth.28.77. [DOI] [PubMed] [Google Scholar]
  91. Payton M., Hu H., Sparrow D., Weiss S. T. Low-level lead exposure and renal function in the Normative Aging Study. Am J Epidemiol. 1994 Nov 1;140(9):821–829. doi: 10.1093/oxfordjournals.aje.a117330. [DOI] [PubMed] [Google Scholar]
  92. Pergande M., Jung K., Precht S., Fels L. M., Herbort C., Stolte H. Changed excretion of urinary proteins and enzymes by chronic exposure to lead. Nephrol Dial Transplant. 1994;9(6):613–618. doi: 10.1093/ndt/9.6.613. [DOI] [PubMed] [Google Scholar]
  93. Perry H. M., Jr, Erlanger M. W., Perry E. F. Increase in the blood pressure of rats chronically fed low levels of lead. Environ Health Perspect. 1988 Jun;78:107–111. doi: 10.1289/ehp.8878107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Pinto de Almeida A. R., Carvalho F. M., Spinola A. G., Rocha H. Renal dysfunction in Brazilian lead workers. Am J Nephrol. 1987;7(6):455–458. doi: 10.1159/000167519. [DOI] [PubMed] [Google Scholar]
  95. Pirkle J. L., Brody D. J., Gunter E. W., Kramer R. A., Paschal D. C., Flegal K. M., Matte T. D. The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES) JAMA. 1994 Jul 27;272(4):284–291. [PubMed] [Google Scholar]
  96. Pirkle J. L., Schwartz J., Landis J. R., Harlan W. R. The relationship between blood lead levels and blood pressure and its cardiovascular risk implications. Am J Epidemiol. 1985 Feb;121(2):246–258. doi: 10.1093/oxfordjournals.aje.a113995. [DOI] [PubMed] [Google Scholar]
  97. Pollock C. A., Ibels L. S. Lead intoxication in paint removal workers on the Sydney Harbour Bridge. Med J Aust. 1986 Dec 1;145(11-12):635–639. doi: 10.5694/j.1326-5377.1986.tb139519.x. [DOI] [PubMed] [Google Scholar]
  98. Pollock C. A., Ibels L. S. Lead nephropathy--a preventable cause of renal failure. Int J Artif Organs. 1988 Mar;11(2):75–78. [PubMed] [Google Scholar]
  99. Price J., Grudzinski A. W., Craswell P. W., Thomas B. J. Bone lead measurements in patients with chronic renal disease studied over time. Arch Environ Health. 1992 Sep-Oct;47(5):330–335. doi: 10.1080/00039896.1992.9938371. [DOI] [PubMed] [Google Scholar]
  100. Price J., Grudzinski A. W., Craswell P. W., Thomas B. J. Repeated bone lead levels in Queensland, Australia--previously a high lead environment. Arch Environ Health. 1992 Jul-Aug;47(4):256–262. doi: 10.1080/00039896.1992.9938358. [DOI] [PubMed] [Google Scholar]
  101. RADOSEVIC Z., SARIC M., BERITIC T., KNEZEVIC J. The kidney in lead poisoning. Br J Ind Med. 1961 Jul;18:222–230. doi: 10.1136/oem.18.3.222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Reynolds P. P., Knapp M. J., Baraf H. S., Holmes E. W. Moonshine and lead. Relationship to the pathogenesis of hyperuricemia in gout. Arthritis Rheum. 1983 Sep;26(9):1057–1064. doi: 10.1002/art.1780260901. [DOI] [PubMed] [Google Scholar]
  103. Ritz E., Wiecek A., Stoeppler M. Lead Nephropathy. Contrib Nephrol. 1987;55:185–191. doi: 10.1159/000413418. [DOI] [PubMed] [Google Scholar]
  104. Rosen J. F. Adverse health effects of lead at low exposure levels: trends in the management of childhood lead poisoning. Toxicology. 1995 Mar 31;97(1-3):11–17. doi: 10.1016/0300-483x(94)02963-u. [DOI] [PubMed] [Google Scholar]
  105. Rosen J. F., Chesney R. W., Hamstra A., DeLuca H. F., Mahaffey K. R. Reduction in 1,25-dihydroxyvitamin D in children with increased lead absorption. N Engl J Med. 1980 May 15;302(20):1128–1131. doi: 10.1056/NEJM198005153022006. [DOI] [PubMed] [Google Scholar]
  106. Schwartz J. Lead, blood pressure, and cardiovascular disease in men. Arch Environ Health. 1995 Jan-Feb;50(1):31–37. doi: 10.1080/00039896.1995.9955010. [DOI] [PubMed] [Google Scholar]
  107. Selevan S. G., Landrigan P. J., Stern F. B., Jones J. H. Mortality of lead smelter workers. Am J Epidemiol. 1985 Oct;122(4):673–683. doi: 10.1093/oxfordjournals.aje.a114146. [DOI] [PubMed] [Google Scholar]
  108. Silbergeld E. K. Implications of new data on lead toxicity for managing and preventing exposure. Environ Health Perspect. 1990 Nov;89:49–54. doi: 10.1289/ehp.908949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Skoczyńska A., Juzwa W., Smolik R., Szechiński J., Behal F. J. Response of the cardiovascular system to catecholamines in rats given small doses of lead. Toxicology. 1986 Jun;39(3):275–289. doi: 10.1016/0300-483x(86)90028-4. [DOI] [PubMed] [Google Scholar]
  110. Sokas R. K., Besarab A., McDiarmid M. A., Shapiro I. M., Bloch P. Sensitivity of in vivo X-ray fluorescence determination of skeletal lead stores. Arch Environ Health. 1990 Sep-Oct;45(5):268–272. doi: 10.1080/00039896.1990.10118744. [DOI] [PubMed] [Google Scholar]
  111. Somervaille L. J., Chettle D. R., Scott M. C. In vivo measurement of lead in bone using x-ray fluorescence. Phys Med Biol. 1985 Sep;30(9):929–943. doi: 10.1088/0031-9155/30/9/005. [DOI] [PubMed] [Google Scholar]
  112. Staessen J. A., Lauwerys R. R., Buchet J. P., Bulpitt C. J., Rondia D., Vanrenterghem Y., Amery A. Impairment of renal function with increasing blood lead concentrations in the general population. The Cadmibel Study Group. N Engl J Med. 1992 Jul 16;327(3):151–156. doi: 10.1056/NEJM199207163270303. [DOI] [PubMed] [Google Scholar]
  113. Staessen J., Yeoman W. B., Fletcher A. E., Markowe H. L., Marmot M. G., Rose G., Semmence A., Shipley M. J., Bulpitt C. J. Blood lead concentration, renal function, and blood pressure in London civil servants. Br J Ind Med. 1990 Jul;47(7):442–447. doi: 10.1136/oem.47.7.442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. TEPPER L. B. RENAL FUNCTION SUBSEQUENT TO CHILDHOOD PLUMBISM. Arch Environ Health. 1963 Jul;7:76–85. doi: 10.1080/00039896.1963.10663496. [DOI] [PubMed] [Google Scholar]
  115. Todd A. C., McNeill F. E., Fowler B. A. In vivo X-ray fluorescence of lead in bone. Environ Res. 1992 Dec;59(2):326–335. doi: 10.1016/s0013-9351(05)80039-8. [DOI] [PubMed] [Google Scholar]
  116. Vander A. J. Chronic effects of lead on the renin-angiotensin system. Environ Health Perspect. 1988 Jun;78:77–83. doi: 10.1289/ehp.887877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Verberk M. M., Willems T. E., Verplanke A. J., De Wolff F. A. Environmental lead and renal effects in children. Arch Environ Health. 1996 Jan-Feb;51(1):83–87. doi: 10.1080/00039896.1996.9935998. [DOI] [PubMed] [Google Scholar]
  118. Verschoor M., Wibowo A., Herber R., van Hemmen J., Zielhuis R. Influence of occupational low-level lead exposure on renal parameters. Am J Ind Med. 1987;12(4):341–351. doi: 10.1002/ajim.4700120402. [DOI] [PubMed] [Google Scholar]
  119. Victery W. Evidence for effects of chronic lead exposure on blood pressure in experimental animals: an overview. Environ Health Perspect. 1988 Jun;78:71–76. doi: 10.1289/ehp.887871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Vyskocil A., Pancl J., Tusl M., Ettlerova E., Semecky V., Kasparová L., Lauwerys R., Bernard A. Dose-related proximal tubular dysfunction in male rats chronically exposed to lead. J Appl Toxicol. 1989 Dec;9(6):395–399. doi: 10.1002/jat.2550090605. [DOI] [PubMed] [Google Scholar]
  121. WILSON V. K., THOMSON M. L., DENT C. E. Amino-aciduria in lead poisoning; a case in childhood. Lancet. 1953 Jul 11;265(6776):66–68. doi: 10.1016/s0140-6736(53)91087-3. [DOI] [PubMed] [Google Scholar]
  122. Waldegger S., Schmidt F., Herzer T., Gulbins E., Schuster A., Biber J., Markovich D., Murer H., Busch A. E., Lang F. Heavy metal mediated inhibition of rBAT-induced amino acid transport. Kidney Int. 1995 Jun;47(6):1677–1681. doi: 10.1038/ki.1995.232. [DOI] [PubMed] [Google Scholar]
  123. Wedeen R. D. In vivo tibial XFR measurement of bone lead. Arch Environ Health. 1990 Mar-Apr;45(2):69–71. doi: 10.1080/00039896.1990.9935927. [DOI] [PubMed] [Google Scholar]
  124. Wedeen R. P., D'Haese P., Van de Vyver F. L., Verpooten G. A., De Broe M. E. Lead nephropathy. Am J Kidney Dis. 1986 Nov;8(5):380–383. doi: 10.1016/s0272-6386(86)80113-5. [DOI] [PubMed] [Google Scholar]
  125. Wedeen R. P., Maesaka J. K., Weiner B., Lipat G. A., Lyons M. M., Vitale L. F., Joselow M. M. Occupational lead nephropathy. Am J Med. 1975 Nov;59(5):630–641. doi: 10.1016/0002-9343(75)90224-7. [DOI] [PubMed] [Google Scholar]
  126. Wedeen R. P. The role of lead in renal failure. Clin Exp Dial Apheresis. 1982;6(2-3):113–146. doi: 10.3109/08860228209050819. [DOI] [PubMed] [Google Scholar]
  127. Wedeen R. P., Ty A., Udasin I., Favata E. A., Jones K. W. Clinical application of in vivo tibial K-XRF for monitoring lead stores. Arch Environ Health. 1995 Sep-Oct;50(5):355–361. doi: 10.1080/00039896.1995.9935967. [DOI] [PubMed] [Google Scholar]
  128. Wedeen R. P. Use of the CaNa2 EDTA Pb-mobilization test to detect occult lead nephropathy. Uremia Invest. 1985;9(2):127–130. doi: 10.3109/08860228509088200. [DOI] [PubMed] [Google Scholar]
  129. Wedeen R. Lead and the gouty kidney. Am J Kidney Dis. 1983 Mar;2(5):559–563. doi: 10.1016/s0272-6386(83)80101-2. [DOI] [PubMed] [Google Scholar]
  130. Weinberger H. L., Post E. M., Schneider T., Helu B., Friedman J. An analysis of 248 initial mobilization tests performed on an ambulatory basis. Am J Dis Child. 1987 Dec;141(12):1266–1270. doi: 10.1001/archpedi.1987.04460120028025. [DOI] [PubMed] [Google Scholar]
  131. Weiss S. T., Muñoz A., Stein A., Sparrow D., Speizer F. E. The relationship of blood lead to blood pressure in a longitudinal study of working men. Am J Epidemiol. 1986 May;123(5):800–808. doi: 10.1093/oxfordjournals.aje.a114309. [DOI] [PubMed] [Google Scholar]
  132. Wolf C., Wallnöfer A., Waldhör T., Vutuc C., Meisinger V., Rüdiger H. W. Effect of lead on blood pressure in occupationally nonexposed men. Am J Ind Med. 1995 Jun;27(6):897–903. doi: 10.1002/ajim.4700270613. [DOI] [PubMed] [Google Scholar]
  133. Wright L. F., Saylor R. P., Cecere F. A. Occult lead intoxication in patients with gout and kidney disease. J Rheumatol. 1984 Aug;11(4):517–520. [PubMed] [Google Scholar]
  134. Yu T. F. Lead nephropathy and gout. Am J Kidney Dis. 1983 Mar;2(5):555–558. doi: 10.1016/s0272-6386(83)80100-0. [DOI] [PubMed] [Google Scholar]
  135. de Kort W. L., Verschoor M. A., Wibowo A. A., van Hemmen J. J. Occupational exposure to lead and blood pressure: a study in 105 workers. Am J Ind Med. 1987;11(2):145–156. doi: 10.1002/ajim.4700110204. [DOI] [PubMed] [Google Scholar]
  136. dos Santos A. C., Colacciopo S., Dal Bó C. M., dos Santos N. A. Occupational exposure to lead, kidney function tests, and blood pressure. Am J Ind Med. 1994 Nov;26(5):635–643. doi: 10.1002/ajim.4700260506. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES